We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+6.6%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$29.1B
AUM Growth
+$628M
(+2.2%)
Cap. Flow
-$702M
Cap. Flow
% of AUM
-2.41%
Top 10 Holdings %
Top 10 Hldgs %
22.73%
Holding
1,138
New
91
Increased
498
Reduced
344
Closed
68
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$407M |
| 2 |
DexCom
DXCM
|
+$326M |
| 3 |
Roper Technologies
ROP
|
+$288M |
| 4 |
PayPal
PYPL
|
+$238M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$498M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$448M |
| 3 |
Fastenal
FAST
|
+$296M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$175M |
| 5 |
Amazon
AMZN
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.26% |
| 2 | Healthcare | 14.35% |
| 3 | Financials | 13.74% |
| 4 | Consumer Discretionary | 12.34% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Vanguard Extended Market ETF
VXF
$30.2B
| $17.2M | 0.06% |
188,505
-161,345
| -46% | -$14.5M |
|
227
VF Corp
VFC
$6.82B
| $17.1M | 0.06% |
324,668
+1,955
| +0.6% | +$113K |
|
228
Vanguard Information Technology ETF
VGT
$134B
| $16.5M | 0.06% |
1,097,520
+104,928
| +11% | +$1.52M |
|
|
NLSN
229
DELISTED
Nielsen Holdings plc
NLSN
| $16.5M | 0.06% |
308,031
-4,331
| -1% | -$230K |
|
230
Vanguard FTSE Emerging Markets ETF
VWO
$118B
| $16.4M | 0.06% |
437,047
+6,247
| +1% | +$233K |
|
231
American Express
AXP
$225B
| $16.3M | 0.06% |
255,269
-10,433
| -4% | -$670K |
|
|
MON
232
DELISTED
Monsanto Co
MON
| $16.3M | 0.06% |
159,610
-5,703
| -3% | -$598K |
|
233
Illinois Tool Works
ITW
$85B
| $16.3M | 0.06% |
136,090
-9,140
| -6% | -$1.06M |
|
234
W.W. Grainger
GWW
$66.8B
| $16.2M | 0.06% |
72,171
+821
| +1% | +$184K |
|
235
Global Payments
GPN
$23.4B
| $15.9M | 0.05% |
206,778
+10,149
| +5% | +$764K |
|
236
United Bankshares
UBSI
$6.61B
| $15.4M | 0.05% |
409,262
+392,045
| +2,277% | +$15M |
|
|
DST
237
DELISTED
DST Systems Inc.
DST
| $15.4M | 0.05% |
260,592
+2,120
| +0.8% | +$128K |
|
238
DuPont de Nemours
DD
$19B
| $15.2M | 0.05% |
115,984
+14,276
| +14% | +$1.9M |
|
|
ALDR
239
DELISTED
Alder Biopharmaceuticals
ALDR
| $15.1M | 0.05% |
459,912
+33,422
| +8% | +$1.02M |
|
240
Oracle
ORCL
$333B
| $14.6M | 0.05% |
372,873
+54,702
| +17% | +$2.23M |
|
241
Gilead Sciences
GILD
$167B
| $14.5M | 0.05% |
183,515
-22,743
| -11% | -$1.85M |
|
|
PPBI
242
DELISTED
Pacific Premier Bancorp
PPBI
| $14.4M | 0.05% |
542,399
+4,001
| +0.7% | +$103K |
|
|
COTV
243
DELISTED
Cotiviti Holdings, Inc.
COTV
| $14.3M | 0.05% |
+427,798
| New | +$12M |
|
244
iShares Russell 3000 ETF
IWV
$19.4B
| $14.3M | 0.05% |
111,487
+1,520
| +1% | +$194K |
|
|
CEB
245
DELISTED
CEB Inc.
CEB
| $14.3M | 0.05% |
262,349
+19,663
| +8% | +$1.18M |
|
246
EOG Resources
EOG
$75.7B
| $14.1M | 0.05% |
145,778
+8,243
| +6% | +$724K |
|
|
DPLO
247
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $14.1M | 0.05% |
502,627
+39,241
| +8% | +$1.32M |
|
|
BNY
248
Bank of New York Mellon
BNY
$106B
| $14M | 0.05% |
352,171
+36,311
| +11% | +$1.45M |
|
249
Pricesmart
PSMT
$5.79B
| $14M | 0.05% |
167,529
+13,179
| +9% | +$1.09M |
|
250
Middleby
MIDD
$6.21B
| $13.9M | 0.05% |
112,208
+3,536
| +3% | +$434K |
|
Similar funds
QCM
Brown Advisory's Q3 2016 Portfolio in Review
As of Q3 2016, Brown Advisory held 1,138 positions worth $29.1B, up 2.2% from $28.5B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Brown Advisory's Q3 2016 filing shows 91 new, 498 increased, 344 reduced and 68 closed positions. Its largest new stake was Fortive: 12,666,674 shares worth $407M. The largest sale was Bristol-Myers Squibb, an estimated $498M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Brown Advisory's largest Q3 2016 buy was Fortive: 12,666,674 shares worth $407M.
- Brown Advisory added most to DexCom in Q3 2016, an estimated $326M increase.
- Brown Advisory's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $498M.
- Brown Advisory fully exited DIAMOND RESORTS INTL, INC in Q3 2016, selling an estimated $53.1M.
- Brown Advisory's ten largest holdings make up 23% of its $29.1B portfolio in Q3 2016.
- Brown Advisory opened 91 new positions and closed 68 in Q3 2016.
- Brown Advisory's portfolio value rose 2.2% quarter-over-quarter to $29.1B.
Based on Brown Advisory's 13F filing for Q3 2016, filed 14 Nov 2016.